0001209191-19-025412.txt : 20190419 0001209191-19-025412.hdr.sgml : 20190419 20190419213539 ACCESSION NUMBER: 0001209191-19-025412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190304 FILED AS OF DATE: 20190419 DATE AS OF CHANGE: 20190419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahboob Vaseem CENTRAL INDEX KEY: 0001655157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 19758443 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-04 0 0001516479 Insys Therapeutics, Inc. INSY 0001655157 Mahboob Vaseem C/O INSYS THERAPEUTICS, INC. 1333 S SPECTRUM BLVD #100 CHANDLER AZ 85286 1 0 0 0 Common Stock 2019-03-04 4 A 0 8083 0.00 A 14083 D Employee Stock Option (right to buy) 6.36 2019-03-04 4 A 0 20935 0.00 A 2029-03-03 Common Stock 20935 20935 D The total reported in Column 5 includes 6,000 RSUs previously reported in Table II on 2/21/18. The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022. /s/ Andrew Long, Attorney-in-fact 2019-04-19